TITLE 31 HEALTH

Section 52. Terminally Ill Patient's Right To Try Investigational Drugs, Biological Products, and Devices, 31-52-1 through 31-52-10.

ARTICLE 2 CHILDHOOD LEAD EXPOSURE CONTROL

31-52-4. Eligibility criteria.

In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:

1. Has a terminal illness;
2. Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;
3. Has been given a recommendation by the physician for an investigational drug, biological product, or device; and
4. Has given written informed consent for the use of the investigational drug, biological product, or device.

(Code 1981, §31-52-4, enacted by Ga. L. 2016, p. 345, § 1/HB 34.)